You are accessing this website using a legacy browser. You may find that certain parts of the new North Central London GP Website do not work as expected. We recommend upgrading your browser to continue.
If you are based within a GP practice please contact the GPIT Helpdesk on 020 3688 1881 or email gpit@camdenccg.nhs.uk to carry out the upgrade
Update on 25 May 2021
Recruitment of participants into the SUMMIT study, the largest lung cancer screening study in Europe, has been completed with a total 13,035 north and east London residents taking part.
For more information on the SUMMIT study please visit the UCLH website.
For queries email uclh.hcpsummitstudy@nhs.net
UCLH is carrying out the SUMMIT Study to detect lung cancer early using low-dose CT (LDCT) screening of at-risk individuals and to support development of a new blood test for early detection of multiple cancer types.
The SUMMIT Study, which began in spring 2019, has two aims: to detect lung cancer early using the proven method of low-dose CT (LDCT) screening of at-risk individuals; and to support development of a new blood test for early detection of multiple cancer types, including lung cancer. In addition, the study will provide evidence to inform a potential future national lung cancer screening programme. The study has so far recruited over 12,000 people aged 55-77 with a smoking history from north and east London.
If you have any questions, contact the study team
e: uclh.HCPsummitstudy@nhs.net.
Find out more information on the SUMMIT Study.
This is an external link. Continuing will take you away from the North Central London GP Website. Please be aware that some external resources may be restricted to NHS Secure Network connections only.
ContinueReport a problem or suggestion using this facility. When describing your problem or suggestion, be as descriptive as possible and include any specific error messages you may see.
This website is for healthcare professionals only. It is not intended for public use.
Continue